… LM Irgens … LM Irgens … King PB, Lie RT, Irgens LM. Risk of spinabifida and orofacial
clefts among infants of mothers with epilepsy and the use of anticonvulsant drugs in Norway …

… Irgens and associates again use data from the Norwegian birth registry to provide …
Irgen et al's findings again emphasise a difference according to gestational age, though this …

Study objective To study secular trends of placental abruption (PA), the effects of demographic
variables and the use of cesarean section (CS) associated with PA. Design A population …

… Lorentz M Irgens , Lorentz M Irgens … Irgens LM, Bergsjø P, Lie RT. The Medical Birth
Registry of Norway. Epidemiological research and surveillance throughout 30 years. …

Background It is unknown whether preeclampsia is a risk marker for subsequent end-stage
renal disease (ESRD). Methods We linked data from the Medical Birth Registry of Norway, …

Background: Total homocysteine (tHcy) measured in serum or plasma is a marker of folate
status and a risk factor for cardiovascular disease. Objective: Our objective was to investigate …

Objective: To use familial patterns of recurrence of pre-eclampsia to investigate whether
paternal genes expressed in the fetus contribute to the mother9s risk of pre-eclampsia and …

… LM Irgens proposed the project and actively chaired the Executive Committee. RG … LM
Irgens with P Schreuder's assistance led the NESS project. PFleming chaired the CESDI planning …

Objective. To determine outcomes, in terms of perinatal and early death, need for treatment,
and morbidity at the time of discharge home, among extremely preterm infants. Design. A …

BACKGROUND/AIM: To describe prevalence, subtypes and severity of cerebral palsy (CP)
in Norway using criteria proposed by the Surveillance of Cerebral Palsy in Europe (SCPE) …